Antibodies are turning the tide in the fight against critical diseases in oncology and immunology. Innovations in monoclonal antibody technology, bispecifics, and antibody-drug conjugates continue to push the envelope of antibody efficacy and safety. Antibody R&D teams are investigating a variety of antibody formats, modernizing scientific workflows with NGS and CRISPR, and comprehensively characterizing lead candidates to bring the next wave of breakthrough antibodies to the market.
The industry requires a new kind of digital solution that can offer a holistic view of antibody research and development, integrating large and disparate data sets to extract timely insights, while providing complete traceability to sequences, cell lines, and production processes.
Antibodies R&D Solution
Benchling’s Antibody R&D Solution is trusted by hundreds of biopharma innovators to accelerate their R&D. It empowers scientists to explore a wide variety of antibody formats with fit-for-purpose tools designed for speed, efficiency, and collaboration. Our modern, digital solution combines the capabilities expected from in silico design tools, ELN, LIMS, and LES into one package, designed from the ground up for antibody R&D.
See Benchling's Antibody R&D Solution in action
Our Customer Experience professionals possess deep scientific expertise, as well as training on information technology best practices. They apply this know-how to support antibody customers across a wide range of R&D teams.
Leverage Benchling's pre-implementation solutions consulting, professional implementation services, and customer success management expertise to help you get the most out of Benchling.
Take advantage of Benchling’s foundational implementation guides, developed by our Customer Experience team to support many antibody R&D functions.